Chinese Journal of Emergency and Critical Care Nursing >
Summary of the best evidence for skin care in adults with Stevens-Johnson syndrome and toxic epidermal necrolysis
Objective To conduct a comprehensive search for evidence relating to skin care for adults with Stevens-Johnson syndrome and toxic epidermal necrolysis and summarize the best evidence. Methods Systematic search of domestic and international databases,guideline websites,and websites of dermatology-related societies was conducted for clinical decisions,guidelines,evidence summaries,expert consensus,systematic reviews,and original research on skin care for adults with Stevens-Johnson syndrome and toxic epidermal necrolysis. The search timeframe was from January 2014 to September 2024. Quality assessment of the literature and extraction of information was performed independently by 4 investigators. Results A total of 12 papers were included,including one clinical decision,five guidelines,two systematic reviews,three expert consensuses,and one original study. Thirty-nine pieces of evidence encompassing five topics were summarized,including formation of multidisciplinary teams,assessment and monitoring,skin barrier care,mucosal system care,health education and follow-up. Conclusion This study summarizes the best evidence for skin care in adults with Stevens-Johnson syndrome and toxic epidermal necrolysis,can provide an evidence-based basis for clinical implementation of skin care.
ZHANG Yumei , WANG Hanmin , GUO Shuping , LANG Xiaoqing , WANG Lijuan , LI Li . Summary of the best evidence for skin care in adults with Stevens-Johnson syndrome and toxic epidermal necrolysis[J]. Chinese Journal of Emergency and Critical Care Nursing, 2025 , 6(7) : 872 -878 . DOI: 10.3761/j.issn.2096-7446.2025.07.019
[1] | Hsu DY, Brieva J, Silverberg NB, et al. Morbidity and mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis in United States adults[J]. J Invest Dermatol, 2016, 136(7):1387-1397. |
[2] | Chaby G, Maldini C, Haddad C, et al. Incidence of and morta-lity from epidermal necrolysis(Stevens-Johnson syndrome/toxic epidermal necrolysis) in France during 2003-16:a four-source capture-recapture estimate[J]. Br J Dermatol, 2020, 182(3):618-624. |
[3] | Frey N, Jossi J, Bodmer M, et al. The epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in the UK[J]. J Investig Dermatol, 2017, 137(6):1240-1247 |
[4] | 刘瑞, 张志彬, 杨科, 等. Stevens-Johnson综合征和中毒性表皮坏死松解症病死率及相关因素的Meta分析[J]. 中国皮肤性病学杂志, 2024, 38(1):65-73. |
Liu R, Zhang ZB, Yang K, et al. Meta-analysis of the case fatality rate and related factors of SJS and TEN[J]. Chin J Der-matovenereology, 2024, 38(1):65-73. | |
[5] | Lerch M, Mainetti C, Beretta-Piccoli BT, et al. Current perspec-tives on Stevens-Johnson syndrome and toxic epidermal necro-lysis[J]. Clin Rev Allergy Immunol, 2018, 54(1):147-176. |
[6] | Hanson LM, Bettencourt AP. Stevens-Johnson syndrome and toxic epidermal necrolysis:a guide for nurses[J]. AACN Adv Crit Care, 2020, 31(3):281-295. |
[7] | 朱政, 胡雁, 邢唯杰, 等. 不同类型循证问题的构成[J]. 护士进修杂志, 2017, 32(21):1991-1994. |
Zhu Z, Hu Y, Xing WJ, et al. The composition of different types of evidence based problems[J]. J Nurses Train, 2017, 32(21):1991-1994. | |
[8] | Dicenso A, Bayley L, Brian Haynes R. Accessing pre-appraised evidence:fine-tuning the 5S model into a 6S model[J]. Evid Based Nurs, 2009, 12(4):99-101. |
[9] | Brouwers MC, Kho ME, Browman GP, et al. AGREE Ⅱ:advanc-ing guideline development,reporting,and evaluation in health care[J]. Prev Med, 2010, 51(5):421-424. |
[10] | Foster MJ, Shurtz S. Making the critical appraisal for sum-maries of evidence(CASE) for evidence-based medicine(EBM):critical appraisal of summaries of evidence[J]. J Med Libr Assoc, 2013, 101(3):192-198. |
[11] | 胡雁, 郝玉芳. 循证护理学[M]. 2版. 北京: 人民卫生出版社, 2018. |
Hu Y, Hao YF. Evidence-based nursing[M]. 2nd ed. Beijing: People’s Medical Publishing House, 2018. | |
[12] | 王春青, 胡雁. JBI证据预分级及证据推荐级别系统(2014版)[J]. 护士进修杂志, 2015, 30(11):964-967. |
Wang CQ, Hu Y. JBI evidence pre-classification and evidence rank system(2014 Edition)[J]. J Nurses Train, 2015, 30(11):964-967. | |
[13] | Lee HY, et al. Stevens-Johnson syn-drome and toxic epidermal necrolysis:Management,prognosis,and long-term sequelae[EB/OL].(2024-04-02)[2024-10-16]. https://www.uptodate.com/contents/stevens-johnson-syndrome-and-toxic-epidermal-necrolysis-ma-nage-ment-prognosis-and-long-term-sequelae. |
[14] | Ingen-Housz-Oro S, Matei I, Gaillet A, et al. French national protocol for diagnosis and management of epidermal necro-lysis in adults(Stevens-Johnson syndrome and toxic epidermal necrolysis)[J]. Ann Dermatol Venereol, 2024, 151(2):103282. |
[15] | Areta KV, Adjunct RF, Arizona BC, et al. Stevens-Johnson syn-drome and toxic epidermal necrolysis[EB/OL].(2022-12-01)[2024-10-16]. https://bestpractice.bmj.com/topics/en-us/237. |
[16] | Seminario-Vidal L, Kroshinsky D, Malachowski SJ, et al. Socie-ty of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults[J]. J Am Acad Dermatol, 2020, 82(6):1553-1567. |
[17] | Creamer D, Walsh SA, Dziewulski P, et al. U.K. guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016[J]. Br J Dermatol, 2016, 174(6):1194-1227. |
[18] | Gupta L, Martin A, Agarwal N, et al. Guidelines for the mana-gement of Stevens-Johnson syndrome/toxic epidermal necroly-sis:an Indian perspective[J]. Indian J Dermatol Venereol Lep-rol, 2016, 82(6):603. |
[19] | Ingen-Housz-Oro S, Schmidt V, Ameri MM, et al. Post-acute phase and sequelae management of epidermal necrolysis:an inter-national,multidisciplinary DELPHI-based consensus[J]. Orpha-net J Rare Dis, 2023, 18(1):33. |
[20] | 中华医学会皮肤性病学分会药物不良反应研究中心. Stevens-Johnson综合征/中毒性表皮坏死松解症诊疗专家共识[J]. 中华皮肤科杂志, 2021, 54(5):376-381. |
Adverse Drug Reaction Research Center of Dermatology Branch of Chinese Medical Association. Expert consensus on the diagnosis and treat-ment of Stevens-Johnson syndrome/toxic epidermal necrolysis[J]. Chin J Dermatol, 2021, 54(5):376-381. | |
[21] | Brüggen MC, Le ST, Walsh S, et al. Supportive care in the acute phase of Stevens-Johnson syndrome and toxic epidermal ne-crolysis:an international,multidisciplinary Delphi-based con-sensus[J]. Br J Dermatol, 2021, 185(3):616-626. |
[22] | Lee JS, Mallitt K, Fischer G, et al. An individual patient data meta-analysis of wound care in patients with toxic epidermal necrolysis[J]. 2024, 65(2):128-142. |
[23] | Castillo B, Vera N, Ortega-Loayza AG, et al. Wound care for Stevens-Johnson syndrome and toxic epidermal necrolysis[J]. J Am Acad Dermatol, 2018, 79(4):764-767.e1. |
[24] | Haravu PN, Gottlieb LJ, Vrouwe SQ. Antishear therapy for ste-vens-Johnson syndrome and toxic epidermal necrolysis:a follow-up study[J]. J Burn Care Res, 2021, 42(6):1152-1161. |
[25] | Surowiecka A, Barańska-Rybak W, Stru?yna J. Multidisciplinary treatment in toxic epidermal necrolysis[J]. Int J Environ Res Public Health, 2023, 20(3):2217. |
[26] | 胡丽, 黄琨, 俞仁涛. Stevens-Johnson综合征和中毒性表皮坏死松解症的疾病进展和治疗转归分析[J]. 中国皮肤性病学杂志, 2022, 36(3):290-294. |
Hu L, Huang K, Yu RT. Disease progression and treatment outcome of Stevens-Johnson syndrome and toxic epidermal necrolysis[J]. Chin J Dermatovenereol, 2022, 36(3):290-294. | |
[27] | Stru?yna J, Surowiecka A, Korzeniowski T, et al. Accuracy of SCORTEN in predicting mortality in toxic epidermal necro-lysis[J]. BMC Med Inform Decis Mak, 2022, 22(1):273. |
[28] | 中华医学会, 中华医学会杂志社, 中华医学会皮肤性病学分会, 等. 药疹基层诊疗指南(2022年)[J]. 中华全科医师杂志, 2022, 21(9):804-813. |
Chinese Medical Association, Chinese Medical Journals Publi-shing House, Dermatology Branch of Chinese Medical Associa-tion, et al. Guideline for primary care of drug eruption(2022)[J]. Chin J Gen Pract, 2022, 21(9):804-813. | |
[29] | 中国老年医学学会烧创伤分会. 含银敷料在创面治疗中应用的全国专家共识(2018版)[J]. 中华烧伤杂志, 2018, 34(11):761-765. |
Burn and Trauma Branch of Chinese Geriatrics Society. National experts consensus on application of silver-contai-Ning dressings in wound therapy(2018 version)[J]. Chin J Burns, 2018, 34(11):761-765. | |
[30] | Revuz J, Penso D, Roujeau JC, et al. Toxic epidermal necroly-sis. Clinical findings and prognosis factors in 87 patients[J]. Arch Dermatol, 1987, 123(9):1160-1165. |
[31] | 何彦, 刘颖怡. Stevens-Johnson综合征及中毒性表皮坏死松解症的早期眼部诊疗管理[J]. 眼科, 2024, 33(4):245-248. |
He Y, Liu YY. The early ophthalmic diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis[J]. Ophthalmol China, 2024, 33(4):245-248. | |
[32] | Komatsu-Fujii T, Ogawa M, Nonoyama S, et al. Recurrence of nivolumab-induced Stevens-Johnson syndrome due to tegafur/gimeracil/oteracil(TS-1R) after nivolumab discontinuation[J]. Eur J Dermatol, 2021, 31(1):98-99. |
/
〈 |
|
〉 |